Pancreatic Cancer Research

ResearcherChinese PLA General HospitalActive in the last 2 years

Jundong Du

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-9863-1928; OpenAlex author ID A5015068001. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2014: 2 papers · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 5

  1. Methyltransferase-like 14 promotes the tumorigenesis and proliferation of pancreatic cancer cells through myc proto-oncogene signaling pathway. Last author DOI 10.25259/cytojournal_105_2024↗
  2. Elevated Transient Receptor Potential Melastatin 8 (TRPM8) Expression Is Correlated with Poor Prognosis in Pancreatic Cancer. Co-author DOI 10.12659/msm.909968↗
  3. MicroRNA‑506 participates in pancreatic cancer pathogenesis by targeting PIM3. Co-author DOI 10.3892/mmr.2015.4109↗
  4. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival. Co-author DOI 10.1002/jso.23475↗
  5. Prognostic significance of microRNA-141 expression and its tumor suppressor function in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s11010-013-1897-y↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Junru Li · 1 shared paper, 2024 · strength 0.24
  2. Hua-Bao Jiao · 4 shared papers, 2014–2018 · strength 0.24
  3. Ziman Zhu · 4 shared papers, 2014–2018 · strength 0.24
  4. Shouwang Cai · 2 shared papers, 2015–2018 · strength 0.14
  5. Bin Hu · 2 shared papers, 2015–2018 · strength 0.14
  6. Xi Zheng · 2 shared papers, 2015–2018 · strength 0.14
  7. Yong-liang Chen · 1 shared paper, 2018 · strength 0.09
  8. Yuliang Tu · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.